Home › NDC Lookup › RxCUI directory › RxCUI 2055989

273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal Syste... — RxCUI 2055989

RxNorm drug concept · Semantic branded drug
RxCUI 2055989 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2055989
Official name273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAnnovera 0.15/0.013 MG per 24HR 273 Day Vaginal System; Annovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)2,468 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 273 DAY ethinyl estradiol 0.000542 MG/HR / seges... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera] RxCUI 2055989

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Segesterone 2055978
    • Ethinyl estradiol / segesterone 2055926
    • Segesterone acetate 2055977
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Annovera 2055984
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / segesterone Vaginal System 2201664
    • Ethinyl estradiol / segesterone acetate Vaginal System 2647638
    • Ethinyl estradiol / segesterone Vaginal Product 2055981
    • Ethinyl estradiol / segesterone acetate Vaginal Product 2659688
    • Ethinyl estradiol / segesterone Vaginal System [Annovera] 2201666
    • Ethinyl estradiol / segesterone acetate Vaginal System [Annovera] 2654440
    • Annovera Vaginal Product 2055988
    • Vaginal System 2199220
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 273 DAY ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System SCD · 2055983
  • Ethinyl estradiol 0.000542 MG/HR SCDC · 2055976
  • Segesterone acetate 0.00625 MG/HR SCDC · 2055979
  • Ethinyl estradiol / segesterone Vaginal System SCDF · 2201664
  • Ethinyl estradiol / segesterone acetate Vaginal System SCDFP · 2647638
  • Ethinyl estradiol / segesterone Vaginal Product SCDG · 2055981
  • Ethinyl estradiol / segesterone acetate Vaginal Product SCDGP · 2659688

Brand-Name Concepts

  • Ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR [Annovera] SBDC · 2055985
  • Ethinyl estradiol / segesterone Vaginal System [Annovera] SBDF · 2201666
  • Ethinyl estradiol / segesterone acetate Vaginal System [Annovera] SBDFP · 2654440
  • Annovera Vaginal Product SBDG · 2055988
  • Annovera BN · 2055984

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2055989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68308-0752-01 1 POUCH in 1 CARTON (68308-752-01) / 30 RING in 1 POUCH Annovera Mayne Pharma 2024-08-16
Observed labelers: Mayne Pharma (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$2,316.5100
Range $2,316.5100–$2,316.5100 · middle 50% $2,316.5100–$2,316.5100 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.